The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review
Open accessAbstract
Background/Aims: Systemic inflammatory response (SIR) is widely considered as a preoperative risk factor for hepatocellular carcinoma (HCC) outcomes. The neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR), two of the prognostic indices, have been investigated in post-therapeutic recurrence and survival of HCC. Here, we quantify the prognostic value of these two biomarkers and evaluate their consistency in different HCC therapies. Methods: A systematic review of electronic database of the Web of Science, Embase, PubMed and the Cochrane Library was conducted to search for associations between the NLR and PLR in the blood and clinical outcomes of HCC. Overall survival (OS) and recurrence-free survival (RFS) were the primary outcomes, and hazard ratios (HRs) and 95% confidence intervals (95% CIs) were explored as effect measures. Subgroup analyses were performed to explore the heterogeneity of different therapies. Results: A total of 24 articles comprising 6318 patients were included in the meta-analysis. Overall, the pooled outcomes revealed that a high NLR before treatment predicted a poor OS (HR: 1.54, 95% CI: 1.34 to 1.76, p<0.001) and poor RFS (HR: 1.45, 95% CI: 1.16 to 1.82, p=0.001). Moreover, an increased PLR predicted a poor OS (HR: 1.63, 95% CI: 1.34 to 1.98, p<0.001) and earlier HCC recurrence (HR: 1.52, 95% CI: 1.21 to 1.91, p<0.001). In addition, both the NLR and PLR were identified as independent risk factors for predicting OS and RFS in HCC patients in a subgroup analysis of different treatment types, including curative or palliative therapy; however, these results were not found in the sorafenib subgroup due to limited clinical research. Conclusion: An increased NLR or PLR indicated poor outcomes for patients with HCC. The NLR and PLR may be considered as reliable and inexpensive biomarkers for making clinical decisions regarding HCC treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, G., Yang, Y., Li, H., Zhang, J., Jiang, N., Li, M., Zhu, H., Zhang, Q., & Chen, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025295 · Cited by 87
Self-citationRetractedInflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Templeton, A. J., McNamara, M. G., Šeruga, B., Vera-Badillo, F. E., Aneja, P., Ocaña, A., Leibowitz-Amit, R., Sonpavde, G., Knox, J. J., Tran, B., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju124 · Cited by 2,829
Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0442 · Cited by 2,493
Yao, F. Y., Ferrell, L., Bass, N. M., Watson, J. J., Bacchetti, P., Venook, A., Ascher, N. L., & Roberts, J. P. (2001) · Hepatology · doi:10.1053/jhep.2001.24563 · Cited by 2,262
Altekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7753 · Cited by 1,694
Loi, S., Sirtaine, N., Piette, F., Salgado, R., Viale, G., Van Eenoo, F., Rouas, G., Francis, P., Crown, J. P. A., Hitre, E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0902 · Cited by 1,632
Epidemiology of Hepatocellular Carcinoma
Bosch, F. X., Ribes, J., Cléries, R., & Díaz, M. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.12.009 · Cited by 1,131
Mlecnik, B., Tosolini, M., Kirilovsky, A., Berger, A., Bindea, G., Meatchi, T., Bruneval, P., Trajanoski, Z., Fridman, W.-H., Pagès, F., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5425 · Cited by 1,009
Lysis of tumor cells by natural killer cells in mice is impeded by platelets.
Nieswandt, B., Hafner, M., Echtenacher, B., & Männel, D. N. (1999) · PubMed · Cited by 832
Proctor, M. J., Morrison, D. S., Talwar, D., Balmer, S. M., Fletcher, C. D., O’Reilly, D. S. J., Foulis, A. K., Horgan, P. G., & McMillan, D. C. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.028 · Cited by 757
The platelet contribution to cancer progression
BAMBACE, N. M., & HOLMES, C. E. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04131.x · Cited by 705
The codependence of angiogenesis and chronic inflammation
Jackson, J. R., Seed, M. P., Kircher, C. H., Willoughby, D. A., & Winkler, J. D. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194526 · Cited by 694
Jaiswal, M., LaRusso, N. F., Burgart, L. J., & Gores, G. J. (2000) · PubMed · Cited by 653
Kuang, D.-M., Zhao, Q., Wu, Y., Peng, C., Wang, J., Xu, Z., Yin, X.-Y., & Zheng, L. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.041 · Cited by 499
Smith, R. A., Bosonnet, L., Raraty, M., Sutton, R., Neoptolemos, J. P., Campbell, F., & Ghaneh, P. (2009) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.12.057 · Cited by 458
Motomura, T., Shirabe, K., Mano, Y., Muto, J., Toshima, T., Umemoto, Y., Fukuhara, T., Uchiyama, H., Ikegami, T., Yoshizumi, T., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.017 · Cited by 448
Koh, C.-H., Bhoo-Pathy, N., Ng, K.-L., Jabir, R. S., Tan, G.-H., See, M.-H., Jamaris, S., & Taib, N. A. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.183 · Cited by 327
Kinoshita, A., Onoda, H., Imai, N., Iwaku, A., Oishi, M., Fushiya, N., Koike, K., Nishino, H., & Tajiri, H. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.354 · Cited by 293
Chan, A. W. H., Chan, S. L., Wong, G. L. H., Wong, V. W. S., Chong, C. C. N., Lai, P. B. S., Chan, H. L. Y., & To, K.-F. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4516-1 · Cited by 263
Unitt, E., Marshall, A., Gelson, W., Rushbrook, S. M., Davies, S., Vowler, S. L., Morris, L. S., Coleman, N., & Alexander, G. J. M. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.12.027 · Cited by 257
Serotonin and Cancer: What Is the Link?
Sarrouilhe, D., Clarhaut, J., Defamie, N., & Mesnil, M. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150114113411 · Cited by 207
Pinato, D. J., Stebbing, J., Ishizuka, M., Khan, S. A., Wasan, H. S., North, B. V., Kubota, K., & Sharma, R. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.022 · Cited by 181
Lai, Q., Castro‐Santa, E., Juri, J. M. R., Pinheiro, R. S., & Lerut, J. P. (2013) · Transplant International · doi:10.1111/tri.12191 · Cited by 145
Li, X., Chen, D., Ouyang, F., Chen, M., Wu, Y., Kuang, D., & Zheng, L. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.023 · Cited by 135
Aliustaoğlu, M., Bilici, A. E., Ustaalıoğlu, B. B. Ö., Konya, V., Gücün, M., Şeker, M., & Gümüş, M. (2009) · Medical Oncology · doi:10.1007/s12032-009-9335-4 · Cited by 128
TGF-β Regulates Hepatocellular Carcinoma Progression by Inducing Treg Cell Polarization
Shen, Y., Wei, Y., Wang, Z., Jing, Y., He, H., Yuan, J., Li, R., Zhao, Q., Wei, L., Yang, T., et al. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373976 · Cited by 115
Li, X., Chen, Z., Xing, Y., Wang, T.-T., Wu, D., Wen, J., Chen, J., Lin, Q., Dong, M., Li, X., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2833-9 · Cited by 108
Ji, F., Liang, Y., Fu, S., Guo, Z., Shu, M., Shen, S., Li, S., Peng, B., Liang, L., & Hua, Y. (2016) · BMC Cancer · doi:10.1186/s12885-016-2189-1 · Cited by 105
Gardini, A. C., Scarpi, E., Faloppi, L., Scartozzi, M., Silvestris, N., Santini, D., de Stefano, G., Marisi, G., Negri, F., Foschi, F. G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11565 · Cited by 99
Wang, Y., Liu, T., Tang, W., Deng, B., Chen, Y., Zhu, J., & Shen, X. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000438631 · Cited by 85
Yang, Z., Zhang, J., Lu, Y., Xu, Q., Tang, B., Wang, Q., Zhang, W., Chen, S., Lu, L., & Chen, X. (2015) · Oncotarget · doi:10.18632/oncotarget.5719 · Cited by 74
Self-citationPretreatment platelet count early predicts extrahepatic metastasis of human hepatoma
Lee, C., Lin, Y., Lin, C., Yen, C., Shen, C., Chang, C., & Hsieh, S. (2015) · Liver International · doi:10.1111/liv.12817 · Cited by 66
Spolverato, G., Maqsood, H., Kim, Y., Margonis, G. A., Luo, T., Ejaz, A. M., & Pawlik, T. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23900 · Cited by 61
Xue, T., Jia, Q., Ge, N., Zhang, B., Wang, Y., Ren, Z., & Ye, S. (2015) · Tumor Biology · doi:10.1007/s13277-015-3281-x · Cited by 53
Wang, D., Wu, M. P., Feng, F., Huang, H., Yang, J., Shen, K., & XIANG, Y. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20122672 · Cited by 41
Aino, H., Sumie, S., Niizeki, T., Kuromatsu, R., Tajiri, N., Nakano, M., Satani, M., Okamura, S., Shimose, S., Miyahara, K., et al. (2016) · Molecular and Clinical Oncology · doi:10.3892/mco.2016.879 · Cited by 37
Tang, X., Huang, J., Xiong, H., Zhang, K., Chen, C., Wei, X., Xu, X., Xie, Q., & Huang, R. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000447811 · Cited by 33
Cited by
Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review
Oura, K., Morishita, A., Tani, J., & Masaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115801 · Cited by 426
Sangro, B., Melero, I., Wadhawan, S., Finn, R. S., Abou-Alfa, G. K., Cheng, A.-L., Yau, T., Furuse, J., Park, J.-W., Boyd, Z., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.026 · Cited by 407
Predictors of early and late hepatocellular carcinoma recurrence
Nevola, R., Ruocco, R., Criscuolo, L., Villani, A., Alfano, M., Beccia, D., Imbriani, S., Claar, E., Cozzolino, D., Sasso, F. C., et al. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i8.1243 · Cited by 274
Özyurt, G., & Binici, N. C. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.007 · Cited by 74
Neutrophil/Lymphocyte, Platelet/Lymphocyte, and Monocyte/Lymphocyte Ratios in Mood Disorders
Marazziti, D., Torrigiani, S., Carbone, M. G., Mucci, F., Flamini, W., Ivaldi, T., & Dell'Osso, L. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867328666210922160116 · Cited by 61
Metadata
- Authors
- Zheng, J., Cai, J., Li, H., Zeng, K., He, L., Fu, H., Zhang, J., Chen, L., Yao, J., Zhang, Y., & Yang, Y.
- Venue
- Cellular Physiology and Biochemistry
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 44
- Issue
- 3
- Pages
- 967-981
- ISSN
- 1015-8987 (ISSN-L)
- 1421-9778
- OpenAlex
- W2770112734
- Cited by
- 260
- References
- 39
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.